Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Aclarion Inc ACON

Aclarion, Inc. is a healthcare technology company. The Company leverages magnetic resonance spectroscopy (MRS), and proprietary biomarkers to optimize clinical treatments. It has developed a software application called NOCISCAN. The product uses the existing MRS capabilities of many commercially available scanners to non-invasively analyze the chemical makeup of intervertebral discs in the... see more

Recent & Breaking News (NDAQ:ACON)

Aclarion Presents at the NIH HEAL Initiative Fall Meeting

GlobeNewswire November 1, 2023

Aclarion Announces Signing of Commercial Agreement With Porter Hospital, an AdventHealth facility, to Bring Nociscan Technology to Denver

GlobeNewswire October 25, 2023

Aclarion Announces Nociscan® Cost-Effectiveness Poster Presented at 45th Annual SMDM Meeting

GlobeNewswire October 24, 2023

Aclarion Announces Signing Strategic Partnership Letter of Intent With ATEC to Advance Commercialization of Nociscan

GlobeNewswire October 23, 2023

Aclarion Provides Updated Investor Presentation and Corporate Update

GlobeNewswire October 2, 2023

Aclarion, Inc. Announces Filing of Delayed 10-Q Quarterly Report

GlobeNewswire August 25, 2023

Aclarion Announces New Commercial Engagement with The Imaging Center, Grand Rapids, MI

GlobeNewswire June 14, 2023

Aclarion Announces Statistically Significant Nociscan® Cost-Effectiveness Abstract Presented at ISASS Annual Meeting

GlobeNewswire June 8, 2023

Aclarion Announces New Engagement with The London Clinic and London Spine Clinic

GlobeNewswire May 30, 2023

Aclarion's Key Opinion Leader Program Adds Ninth Surgeon Advisor With Addition of Dean Karahalios, MD

GlobeNewswire May 23, 2023

Aclarion, Inc. Announces Delayed 10-Q Filing

GlobeNewswire May 23, 2023

Aclarion Announces Non-Convertible Debt Financing to Achieve Three Critical Catalysts

GlobeNewswire May 19, 2023

Aclarion Appoints Nicholas Theodore, MD as Principal Investigator for CLARITY Post-Market Trial Evaluating Nociscan in the Diagnosis and Treatment of Chronic Low Back Pain

GlobeNewswire May 2, 2023

Aclarion to Host Thought Leadership Symposium at SPINEWEEK 2023

GlobeNewswire April 28, 2023

Aclarion Announces Publication of 2YR Outcomes in Groundbreaking Clinical Trial

GlobeNewswire April 24, 2023

Aclarion Announces Alpesh Patel MD MBA as a Key Opinion Leader Physician Advisor

GlobeNewswire March 7, 2023

Aclarion Supports Thought Leadership at the 2nd Annual Sonntag Spine Symposium

GlobeNewswire February 15, 2023

Gregory Basil MD to Join Aclarion as a Key Opinion Leader Surgeon Advisor 

GlobeNewswire January 31, 2023

Aclarion Appoints George Frey MD as Seventh Key Opinion Leader Surgeon Advisor

GlobeNewswire January 17, 2023

Aclarion to Present at the Jan 26th Virtual Investor Summit Microcap Event

Newsfile January 17, 2023